Trials / Completed

CompletedNCT01476098

A Study to Investigate the Effect of SB-705498 on Chronic Cough

Two Part Study to Investigate Pharmacokinetics (PK) & Pharamcodynamics (PD) of SB-705498 in Cough. Part A:Open Label Study in Healthy Subjects to Determine Exposure to SB-705498. Part B:Double-blind, Placebo Controlled, Cross Over Study to Investigate Effect of SB-705498 on Capsaicin Induced Cough and 24 Hour Cough Counts in Cough Patients

Status: Completed
Phase: Phase 2
Study type: Interventional
Enrollment: 21 (actual)

Sponsor: GlaxoSmithKline · Industry
Sex: All
Age: 18 Years – 75 Years
Healthy volunteers: Not accepted

Summary

This study is designed to loook at the affect of oral SB-705498 on cough following an inhaled capsaicin challenge

Conditions

Rhinitis

Interventions

Type	Name	Description
DRUG	Placebo	SB-705498 placebo
DRUG	SB-705498	400 or 600mg oral SB-705498

Timeline

Start date: 2011-04-01
Primary completion: 2011-12-01
Completion: 2012-01-01
First posted: 2011-11-22
Last updated: 2016-12-01

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01476098. Inclusion in this directory is not an endorsement.